Open AccessWhich chemotherapy regimen might be the best for the second-line treatment of patients with small-cell lung cancer?
Author(s) -
Oğuzhan Yıldız,
Mustafa Karaağaç,
Melek Karakurt Eryılmaz,
Mehmet Artaç
Publication year - 2021
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2021.0041
Subject(s) - medicine , regimen , chemotherapy , cyclophosphamide , vincristine , topotecan , univariate analysis , lung cancer , oncology , retrospective cohort study , combination chemotherapy , chemotherapy regimen , multivariate analysis , surgery , gastroenterology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom